1. Hematopoietic growth factors;Crawford,2001
2. 2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines;Ozer;J Clin Oncol,2000
3. Superiority of dose-dense (DD) over conventional scheduling (CS) and equivalence of sequential (SC) vs combination adjuvant chemotherapy (CC) for node-positive breast cancer (CALGFB 9741, INT C9741);Citron;Paper presented at 25th Annual San Antonio Breast Cancer Symposium,2002
4. Reduction in the incidence of chemotherapy-induced febrile neutropenia in patients with small cell lung cancer by granulocyte colony-stimulating factor (R-metG-CSF);Crawford;N Engl J Med,1991
5. Pegfilgrastim administered once per cycle reduces incidence of chemotherapy-induced neutropenia;Crawford;Drugs,2002